Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Nicox
(OTCEM:NICXF)
Intraday
$0.44
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.44
0
[0.00%]
At close: Dec 28
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Nicox Stock (OTC:NICXF)
Nicox Stock (OTC: NICXF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 05, 2019
Stocks That Hit 52-Week Lows On Thursday
Lisa Levin
-
Dec 5, 2019, 10:33AM
Friday, August 02, 2019
Stocks That Set New 52-Week Lows Friday Morning
Lisa Levin
-
Aug 2, 2019, 10:46AM
Monday, December 17, 2018
Nicox, Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize NCX 470 in the Chinese market
Charles Gross
-
Dec 17, 2018, 4:02AM
Wednesday, June 06, 2018
Nicox Announces Research Collaboration on Novel Ophthalmic Therapeutics with Ironwood Pharmaceuticals
Benzinga
-
Jun 6, 2018, 4:42AM
Friday, December 01, 2017
FDA Decisions In November: The Month In Review
Benzinga
-
Dec 1, 2017, 2:05PM
Monday, February 27, 2017
Valeant's Bausch + Lomb and Nicox Resubmit NDA for Novel Glaucoma Candidate Latanoprostene Bunod
Benzinga
-
Feb 27, 2017, 4:16AM
Wednesday, July 06, 2016
Valeant's Bausch + Lomb, Nicox Announce Publication of Latanoprostene Bunod Ophthalmic Solution 0.024% Phase 3 Study Results in American Journal of Ophthalmology
Benzinga
-
Jul 6, 2016, 4:46AM
Tuesday, November 10, 2015
Nicox, Fera Pharmaceuticals Sign Exclusive License Agreement for Naproxcinod in US
Benzinga
-
Nov 10, 2015, 4:20AM
Monday, February 02, 2015
Nicox Announces Exclusive License Agreement with InSite Vision for AzaSite, BromSite in Europe
Benzinga
-
Feb 2, 2015, 4:29AM
Monday, January 26, 2015
Nicox Announces Successful Pre-NDA meeting with FDA on AC-170 Clinical Package
Benzinga
-
Jan 26, 2015, 5:49AM
Monday, November 17, 2014
Valeant Acquires Nicox's US Diagnostics Subsidiary Nicox Inc.,for Up to $20M
Benzinga
-
Nov 17, 2014, 5:22AM
Thursday, June 19, 2014
Nicox and Sequenom Announce Expanded Access to RetnaGene Test Portfolio in US
Benzinga
-
Jun 19, 2014, 5:32AM
Thursday, January 16, 2014
Sequenom Grants Exclusive Promotion and Marketing Rights to Nicox for RetnaGene AMD Test in North America
Benzinga
-
Jan 16, 2014, 5:43AM
